SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/D800D9880124EAEC458A08773216759BD9730790182BDE6AB3091B6ACB5F73C329C391C2A55FAA1210073978CC14DB8C>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/D800D9880124EAEC458A08773216759BD9730790182BDE6AB3091B6ACB5F73C329C391C2A55FAA1210073978CC14DB8C
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/D800D9880124EAEC458A08773216759BD9730790182BDE6AB3091B6ACB5F73C329C391C2A55FAA1210073978CC14DB8C
http://www.w3.org/2000/01/rdf-schema#comment
"RXR agonist Bexarotene effectively reduces drug resistance via regulation of RFX1 in embryonic carcinoma cells."
xsd:string
http://purl.uniprot.org/uniprot/#_D477EE0B108CCC07C79C30C136260A6E17AE4F09A30697CAC82D72A4CAA5F1AA5AC3C03582DA0BEE97716893C60AC79F
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/D800D9880124EAEC458A08773216759BD9730790182BDE6AB3091B6ACB5F73C329C391C2A55FAA1210073978CC14DB8C
http://purl.uniprot.org/uniprot/P22670
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/D800D9880124EAEC458A08773216759BD9730790182BDE6AB3091B6ACB5F73C329C391C2A55FAA1210073978CC14DB8C
http://purl.uniprot.org/uniprot/#_P22670-mappedCitation-37301270
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/D800D9880124EAEC458A08773216759BD9730790182BDE6AB3091B6ACB5F73C329C391C2A55FAA1210073978CC14DB8C